FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+114.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.31B
AUM Growth
+$247M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$54.1M
2
+$28.2M
3
+$24.7M
4
SLP icon
Simulations Plus
SLP
+$21.1M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$19.7M

Top Sells

1
+$90.6M
2
+$34.4M
3
+$32.3M
4
CDTX
Cidara Therapeutics
CDTX
+$28M
5
MRUS
Merus
MRUS
+$21.1M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPCE icon
26
Neuropace
NPCE
$544M
$20.8M 1.59%
1,349,482
-10,589
MDXG icon
27
MiMedx Group
MDXG
$567M
$20.6M 1.57%
3,039,341
-613,611
ORGO icon
28
Organogenesis Holdings
ORGO
$314M
$20M 1.53%
3,862,820
-3,635,091
SEPN
29
Septerna Inc
SEPN
$1.39B
$17.3M 1.32%
+620,811
ABVX
30
Abivax
ABVX
$7.93B
$12M 0.91%
88,674
-7,281
BFLY icon
31
Butterfly Network
BFLY
$1.2B
$10.7M 0.82%
2,812,131
+1,684,133
DYN icon
32
Dyne Therapeutics
DYN
$2.82B
$3.04M 0.23%
+155,231
IWO icon
33
iShares Russell 2000 Growth ETF
IWO
$14.1B
$245K 0.02%
+760
CDTX
34
DELISTED
Cidara Therapeutics
CDTX
– –
-292,657
EVH icon
35
Evolent Health
EVH
$472M
– –
-545,282
GPCR icon
36
Structure Therapeutics
GPCR
$2.7B
– –
-197,350
MRUS
37
DELISTED
Merus
MRUS
– –
-224,080
RARE icon
38
Ultragenyx Pharmaceutical
RARE
$2.16B
– –
-285,699
RDNT icon
39
RadNet
RDNT
$4.25B
– –
-42,280
RGEN icon
40
Repligen
RGEN
$6.92B
– –
-41,427
SENS icon
41
Senseonics Holdings Inc
SENS
$347M
– –
-900,382
LENZ
42
LENZ Therapeutics
LENZ
$219M
– –
-693,044
TECX
43
Tectonic Therapeutic
TECX
$547M
– –
-202,393
PHLT
44
DELISTED
Performant Healthcare Inc
PHLT
– –
-11,718,612
CAI
45
Caris Life Sciences
CAI
$4.67B
– –
-403,924
ALHC icon
46
Alignment Healthcare
ALHC
$3.2B
– –
-203,138
ADMA icon
47
ADMA Biologics
ADMA
$1.84B
– –
-1,069,233
1
2